Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months
By: theblockbeats.news|2025/09/02 13:52:27
BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.
WEEX causa sensación en BlockchainRIO 2025
Escenario global de WEEX: De Singapur a Dubái
También te puede interesar
Compartir
Ganadores
Últimas noticias sobre criptomonedas
11:22
Zama: Sealed-Bid Dutch Auction Token Sale to Start on January 12
11:20
Michael Saylor hints at more purchases, 100% win-rate trader predicts market going long again
10:19
BiyaPay Analyst: HashKey's Listing Imminent, Hong Kong Stock Market Welcomes First Cryptocurrency Compliance Giant
09:53
Abraxas Capital has allocated half of its funds to purchase HYPE spot, with a position reaching $56 million.
09:23
BNP Paribas: Fed to Continue Cutting Interest Rates Next Year, Room for Further Decline in US Bond Yields
Leer más
Comunitario
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]